Amod Athavale, BPharm, PhD; Nandini Hadker, MA; Elizabeth Stringer, MD, MSc; Swagata Karkare, MS, MPH; Aparna Deshpande, BS; Michelle Lim-Watson, MPH, MBA; Julie Krop, MD
This study investigated patient preferences for administration-related attributes of treatments used to reduce the risk of recurrent preterm birth and drivers of treatment adherence propensity and was funded by AMAG Pharmaceuticals, Inc. All materials have undergone peer review according to Women’s Healthcare standards.
Download here to view the full study.
Powered by  www.HealthComMedia.com |
©2022 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder
